Technical Analysis for ABEO - Abeona Therapeutics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.26 | 2.19% | 0.07 |
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Calm After Storm | Range Contraction | 2.19% |
| Alert | Time |
|---|---|
| Possible NR7 | about 7 hours ago |
| 60 Minute Opening Range Breakout | about 11 hours ago |
| Up 5% | about 11 hours ago |
| 2x Volume Pace | about 11 hours ago |
| 1.5x Volume Pace | about 11 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/09/2024
Abeona Therapeutics Inc. Description
Abeona Therapeutics, Inc., formerly PlasmaTech Biopharmaceuticals, Inc., is focused on developing and delivering gene therapy and plasma-based products for severe and rare diseases. The Company's lead program includes adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB). Its product pipeline includes ABO-101 (sc AAV9 NAGLU), which is used for the treatment of MPS III B; ABO-102 (sc AAV9 SGSH), which is used for the treatment of MPS III A; ABO-201 (sc AAV9 CLN3), which is used for the treatment of Juvenile Batten Disease (JBD); ABO-301 (AAV LK19 FANCC), which is used for the treatment of Fanconi Anemia (FA), and clustered, regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) gene editing, which is used for treatment of other rare blood diseases. The Company offers two platforms: Salt Diafiltration (SDF) Process and Polymer Hydrogel Technology (PHT).
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Biology Emerging Technologies Rare Diseases Molecular Biology Genetics Gene Therapy Genetic Engineering Anemia CRISPR Genome Editing Adeno Associated Virus Cas9 Severe And Rare Diseases Blood Diseases Fanconi Anemia
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.01 |
| 52 Week Low | 2.85 |
| Average Volume | 541,411 |
| 200-Day Moving Average | 5.04 |
| 50-Day Moving Average | 7.22 |
| 20-Day Moving Average | 6.74 |
| 10-Day Moving Average | 5.88 |
| Average True Range | 0.68 |
| RSI (14) | 21.26 |
| ADX | 30.34 |
| +DI | 15.38 |
| -DI | 45.92 |
| Chandelier Exit (Long, 3 ATRs) | 6.42 |
| Chandelier Exit (Short, 3 ATRs) | 5.08 |
| Upper Bollinger Bands | 10.25 |
| Lower Bollinger Band | 3.24 |
| Percent B (%b) | 0.0 |
| BandWidth | 103.92 |
| MACD Line | -0.93 |
| MACD Signal Line | -0.37 |
| MACD Histogram | -0.5549 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.53 | ||||
| Resistance 3 (R3) | 3.54 | 3.46 | 3.49 | ||
| Resistance 2 (R2) | 3.46 | 3.39 | 3.46 | 3.47 | |
| Resistance 1 (R1) | 3.36 | 3.35 | 3.32 | 3.35 | 3.45 |
| Pivot Point | 3.28 | 3.28 | 3.26 | 3.28 | 3.28 |
| Support 1 (S1) | 3.18 | 3.21 | 3.14 | 3.17 | 3.07 |
| Support 2 (S2) | 3.10 | 3.17 | 3.10 | 3.05 | |
| Support 3 (S3) | 3.00 | 3.10 | 3.04 | ||
| Support 4 (S4) | 2.99 |
